Argent Biopharma Limited (RGT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,024 | 703 | 240 | 1,787 | 5,433 |
| Receivables | 376 | 477 | 531 | 3,347 | 2,349 |
| Inventories | 133 | 875 | 1,260 | 2,224 | 872 |
| Other current assets | 0 | 0 | 0 | 0 | 280 |
| TOTAL | $2,030 | $2,740 | $2,428 | $8,155 | $9,481 |
| Non-Current Assets | |||||
| PPE Net | 438 | 6,720 | 7,453 | 9,702 | 7,141 |
| Investments And Advances | N/A | 1,327 | N/A | 156 | N/A |
| Intangibles | N/A | N/A | N/A | 5,384 | 7,049 |
| Other Non-Current Assets | 0 | 0 | 0 | 156 | 564 |
| TOTAL | $438 | $8,047 | $7,453 | $15,398 | $14,754 |
| Total Assets | $2,468 | $10,787 | $9,881 | $23,553 | $24,236 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,930 | N/A | N/A | 2,100 | 8,725 |
| Accounts payable and accrued liabilities | 1,813 | 957 | 2,186 | 2,503 | 1,222 |
| Other current liabilities | N/A | 8,680 | 9,180 | 2,318 | 4,290 |
| TOTAL | $10,830 | $12,176 | $13,259 | $9,119 | $15,021 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 554 | 585 | 1,381 | N/A |
| Other Non-Current Liabilities | 19 | 689 | 650 | 563 | 9 |
| TOTAL | $267 | $4,436 | $4,757 | $4,540 | $4,280 |
| Total Liabilities | $11,098 | $16,612 | $18,015 | $13,659 | $19,300 |
| Shareholders' Equity | |||||
| Common Shares | 138,587 | 123,289 | 103,710 | 97,439 | 77,751 |
| Retained earnings | -147,513 | -129,668 | -119,169 | -94,764 | -76,093 |
| Other shareholders' equity | 296 | 1,227 | 7,953 | 8,558 | 6,938 |
| TOTAL | $-8,630 | $-5,152 | $-7,506 | $11,233 | $8,596 |
| Total Liabilities And Equity | $2,468 | $11,460 | $10,509 | $24,893 | $27,897 |